Literature DB >> 15825155

Pathology of radiation and anthracycline cardiotoxicity.

Gerald J Berry1, Michelle Jorden.   

Abstract

Radiation-induced heart disease (RIHD) and anthracycline cardiotoxicity are two patterns of cardiac dysfunction caused by therapeutic interventions to treat malignancies. They occur in both the pediatric and adult populations and there is evidence to suggest that pediatric patients are at greater risk. This is due in part to the longer survival rates but also reflects increased susceptibility to the attendant complications caused by both therapies. Radiation can cause injury to all the components of the heart, including the vasculature, while anthracycline toxicity is generally limited to the myocardium. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15825155     DOI: 10.1002/pbc.20346

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  16 in total

1.  Late effects in cancer survivors: “the shared care model”.

Authors:  Aziza Shad; Scott N Myers; Karen Hennessy
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

Review 2.  Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.

Authors:  Kirsten K Ness; Saro H Armenian; Nina Kadan-Lottick; James G Gurney
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

3.  Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial.

Authors:  John A Kalapurakal; Mahesh Gopalakrishnan; David O Walterhouse; Cynthia K Rigsby; Alfred Rademaker; Irene Helenowski; Sandy Kessel; Karen Morano; Fran Laurie; Ken Ulin; Natia Esiashvili; Howard Katzenstein; Karen Marcus; David S Followill; Suzanne L Wolden; Anita Mahajan; Thomas J Fitzgerald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-08-29       Impact factor: 7.038

4.  Risk factors for enlargement of cardiac silhouette on chest radiography after radiotherapy for esophageal cancer.

Authors:  Ryuta Sasamoto; Emiko Tsuchida; Tadashi Sugita; Yasuo Matsumoto; Eisuke Abe; Keisuke Sasai
Journal:  Radiat Med       Date:  2006-07

Review 5.  Risk-based health monitoring of childhood cancer survivors: a report from the Children's Oncology Group.

Authors:  Susan B Nunez; Daniel A Mulrooney; Caroline Laverdiere; Melissa M Hudson
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

6.  Medical screening participation in the childhood cancer survivor study.

Authors:  Cheryl L Cox; Melissa M Hudson; Ann Mertens; Kevin Oeffinger; John Whitton; Michele Montgomery; Leslie L Robison
Journal:  Arch Intern Med       Date:  2009-03-09

Review 7.  Caring for adult survivors of childhood cancer.

Authors:  Daniel A Mulrooney; Joseph P Neglia; Melissa M Hudson
Journal:  Curr Treat Options Oncol       Date:  2008-03-25

Review 8.  Evaluation and management of patients with heart disease and cancer: cardio-oncology.

Authors:  Joerg Herrmann; Amir Lerman; Nicole P Sandhu; Hector R Villarraga; Sharon L Mulvagh; Manish Kohli
Journal:  Mayo Clin Proc       Date:  2014-09       Impact factor: 7.616

9.  Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms.

Authors:  Almudena Cascales; Francisco Pastor-Quirante; Beatriz Sánchez-Vega; Ginés Luengo-Gil; Javier Corral; Guzmán Ortuño-Pacheco; Vicente Vicente; Francisco Ayala de la Peña
Journal:  Oncologist       Date:  2013-04-10

Review 10.  Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.